Report cover image

Global Barbiturate Drugs Market Growth, Size, Trends Analysis - By Drug Type, By Application, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published Jun 23, 2025
Length 269 Pages
SKU # SPER20222485

Description

Barbiturate Drugs Market Introduction and Overview

According to SPER market research, ‘Global Barbiturate Drugs Market Size- By Drug Type, By Application, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Barbiturate Drugs Market is predicted to reach 670.86 million by 2034 with a CAGR of 3.23%.

Barbiturates are a class of medications that predominantly affect the central nervous system. They were previously employed for a range of medical applications, including sedation, hypnotics, and anticonvulsants. Barbiturates reduce the activity of the central nervous system, resulting in drowsiness and relaxation.

Restraints:

The market for barbiturate drugs is experiencing difficulties because of safety issues that limit their use. Barbiturates increase the risk of overdose because of their narrow therapeutic index, which has a tiny difference between a safe and a lethal dose. Respiratory depression is a severe risk, especially when combined with other central nervous system depressants like alcohol or opioids, which can worsen breathing issues.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered

By Drug Type, By Application, By Distribution Channel

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Abbott Laboratories, AbbVie Inc, Akorn, Inc, Centurion Healthcare Private Limited, Ethypharm, GSK plc, Intas Pharmaceuticals Ltd, Johnson & Johnson, Merck & Co, Inc, Novartis AG.

Global Barbiturate Drugs Market Segmentation:

By Drug Type:

Based on the Drug Type, Global Barbiturate Drugs Market is segmented as; Long-Acting, Short-Acting, Ultra-Short Acting Barbiturate, Combination Drugs.

By Application:

Based on the Application, Global Barbiturate Drugs Market is segmented as; Insomnia, Epilepsy, Sedation.

By Distribution Channel:

Based on the Distribution Channel, Global Barbiturate Drugs Market is segmented as; Hospital pharmacies, Retail pharmacies, Online pharmacies.

By Region:

This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

269 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Barbiturate Drugs Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Barbiturate Drugs Market
7. Global Barbiturate Drugs Market, By Drug Type (USD Million) 2021-2034
7.1. Long-acting barbiturate
7.2. Short-acting barbiturate
7.3. Ultra-short acting barbiturate
7.4. Combination drugs
8. Global Barbiturate Drugs Market, By Application (USD Million) 2021-2034
8.1. Insomnia
8.2. Epilepsy
8.3. Sedation
8.4. Other applications
9. Global Barbiturate Drugs Market, By Distribution Channel (USD Million) 2021-2034
9.1. Hospital pharmacies
9.2. Retail pharmacies
9.3. Online pharmacies
10. Global Barbiturate Drugs Market, (USD Million) 2021-2034
10.1. Global Barbiturate Drugs Market Size and Market Share
11. Global Barbiturate Drugs Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. AbbVie Inc
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Akorn, Inc
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Centurion Healthcare Private Limited
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Ethypharm
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. GSK plc
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Intas Pharmaceuticals Ltd
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Johnson & Johnson
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Merck & Co., Inc
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Novartis AG
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.